American Association for Precision Medicine Announces Agenda and Keynote Roster for COVID-19 Global Summit (CGS2020)

The CGS2020 virtual conference is a must-attend event for frontline COVID-19 clinicians, scientists, clinical research professionals, and health policy administrators, as they look for international collaborations to seek agile solutions during this challenging pandemic

SAN FRANCISCO, Calif., April 17, 2020: On Saturday, April 18, 2020, from 9 a.m. to 1:30 p.m. PST, the world’s leading doctors, entrepreneurs, cancer and COVID-19 survivors along with experts in the field of precision medicine and digital health will convene virtually at the COVID-19 Global Summit (CGS2020), organized by American Association for Precision Medicine (AAPM) in partnership with Gryt Health. This unique snapshot of an academic-industrial-governmental nexus aims to create and share actionable rapid solutions as they face the challenges of this fast-moving COVID-19 disease.

“As we know, the novel coronavirus is a formidable and a common virulent enemy of mankind and we must collaborate globally to meet the challenges that this pandemic poses and make sure we are well prepared for any future outbreaks,” said Dr. Prasun Mishra, CEO and Founder of the Association of Medicine. “We assembled the world’s top medical minds, biotech executives, scientists and entrepreneurs as summit speakers in a matter of days, revealing an unprecedented level of commitment to develop, shape, and apply cutting-edge solutions against an evolving fast-moving scenario.”

Dangerous virulence requires agile collaborative execution and out-of-the box ideas from the best minds

CGS2020 Opening Keynote Panel will focus on Precision Medicine in Cancer & COVID-19

CGS2020 Distinguished Speakers include:

·       Dr. George Albert Fisher, Professor of Medicine, GI-Oncologist, Stanford Cancer Institute

·       Dr. Chelsea Boet, Colon Cancer survivor, Med-Peds Physician, Spectrum Health

·       Dr. Jacob Glanville, Founder & CEO, Distributedbio

·       Dr. Prasun Mishra, CEO & Founder AAPM

·       Dr. Morhaf Al Achkar, Lung Cancer survivor, Family Physician UW Medicine

·       Dr. Hetal Gor, COVID-19 Patient, Ob-Gyn Physician Womens OWN Ob-Gyn

·       Dr. Rick Pesano, CEO, Pesano LLC, Ex VP & Chief Medical Officer, Quest Diagnostics

·       Craig Lipset, Former Head of Innovation, Pfizer

·       Dr. Jamie Platt, CEO, BRIDGenomics

·       Dr. Bassam El-Fahmawi, President & Chief Technology Officer, Mawi DNA

·       Ritesh Patel, Chief Digital Officer, Ogilvy Health

·       Dr. Deepak Asudani, Director, Clinical Operations UC San Diego

·       Dr. Piyush Mathur, Anesthesiologist & Intensivist, Cleveland Clinic

·       Kent Thoelke, EVP & Chief Scientific Officer, PRA Health Sciences

·       Peyton Howell, Chief Commercial & Strategy Officer, Parexel

·       Dr. Robert Hariri, Chairman & CEO, Celularity, Serial Entrepreneur, Founder and former CSO and CEO, Celgene (now a subsidiary of Bristol Myers Squibb)

CGS2020 Closing Keynote Panel will focus on Collaborations to Disrupt the Pandemic

For the latest speaker line-up, visit the event website: (download agenda:; register and join the summit at our Virtual Platform:

This groundbreaking summit aims to equip attendees with strategic insights and network of luminaries in their respective efforts to combat COVID-19. Topics include:

·       Precision Medicine in Cancer & COVID-19 (moderated by Dr. Prasun Mishra, CEO & Founder AAPM)

·       Bench to Bedside – The Coronavirus Treatment Story (moderated by Dr. Lonnie Bookbinder CEO, ARIZ Precision Medicine)

·       COVID-19 Diagnostics, a 360 View of Novel Advancements in Testing (moderated by Dr. Kamala Maddali, CEO, HealthCollaborations LLC)

·       Logistic Challenges & the Artificially Intelligent Data-Science Approach (co-moderated by Horacio Enriquez, Suppliers Council Chairman, BSMA & Martin Ciupa, CEO, Mental Imagery Srli)

·       Patient-Centric Clinical Trial Innovations amidst COVID-19 (moderated by Dr. Arun Sivanandam, Clinical Trials Specialist, Stanford Cancer Institute, Stanford University)

·       Collaborations to Disrupt the Pandemic (moderated by Dr. Prasun Mishra, CEO & Founder AAPM)

Donate to support the cause:

About American Association for Precision Medicine (AAPM)

AAPM is a non-profit organization catalyzing healthcare transformation by fostering breakthrough innovation in prevention, early detection, treatment, and care. AAPM is on a mission to accelerate the field of precision medicine through research, education, communication, and collaboration to foster new medical breakthroughs.

No alt text provided for this image

Through its programs and services, AAPM accelerates dissemination of new research findings among scientists and others dedicated to finding the right drugs, for the right patients, at the right dose, through the right route, and at the right time. AAPM promotes science education and training to facilitate ‘precision medical care’, based on an individual’s genomic, environment, and lifestyle differences enabling more precise methods to prevent and treat diseases. AAPM also facilitates a dialogue between the 4-P’s of precision medicine: patients, providers, public health planners (government), and payers to work together to achieve the goal of delivering improved outcomes at reduced costs.

In response to the COVID-19 pandemic, AAPM rapidly launched the AAPM Coronavirus Taskforce (ACT) in January 2020. ACT brings together a worldwide network of experts spanning clinical, scientific, technical, and advocacy backgrounds. The Taskforce’s Mission is to develop, deliver and disseminate strategies for COVID-19 specific prevention, diagnostics, therapeutics, supply chain logistics, artificial Intelligence-driven solutions, impact investment funding opportunities, and other patient-centric precision medicine innovation techniques. Please join us in our mission to save lives, visit

Leave a Reply

Your email address will not be published. Required fields are marked *